Altered Baseline of  Plasma Glucagon Level in pre-Obese to very Obese Persons

Ronny Lesmana; William Giovanni Mulyanaga; Siti Baitul Mukarromah; Hanna Goenawan; Meita Darmayanti; Adhi sugianli

doi:10.15294/kemas.v17i1.24703

Altered Baseline of Plasma Glucagon Level in pre-Obese to very Obese Persons

Ronny Lesmana⁽¹⁾, William Giovanni Mulyanaga⁽²⁾, Siti Baitul Mukarromah⁽³⁾, Hanna Goenawan⁽⁴⁾, Meita Darmayanti⁽⁵⁾, Adhi sugianli⁽⁶⁾,

DOI: https://doi.org/10.15294/kemas.v17i1.24703

(1) Faculty of Medicine Universitas Padjadjaran
(2) Faculty of Medicine Universitas Padjadjaran
(3) Universitas Negeri Semarang
(4) Faculty of Medicine Universitas Padjadjaran
(5) Faculty of Medicine Universitas Padjadjaran
(6) FK unpad

Abstract

“Bihormonal hypothesis” is disturbances of both insulin and glucagon in diabetes mellitus. It resulted in a high blood glucose level. Interestingly, as one of Diabetes Mellitus’s risk factors and metabolic disorders, obesity may also play role in altering homeostasis and regulation of glucose metabolism in blood and its utilization in tissues. Unfortunately, there is limited information about the alteration of glucagon levels in various degrees of obesity. This research objective is to learn the plasma glucagon levels alteration in pre-obese, obese, and very obese persons in Jatinangor in 2015. We had observed 31 obese female subjects in one village. This study was conducted using descriptive quantitative with cross-sectional design. Blood vein samples from the left arm were collected, stored, and transferred to Dr.Hasan Sadikin General Hospital. Glucagon plasma was measured by the ELISA method. We discovered an interesting pattern that showed a correlation between glucose level and the glucagon level in a very obese group. We observed average glucose level is declined and linearly associate with the glucagon level from pre obese to obese and to very obese group. The average level of glucagon in the pre-obese group is 158.62 pg/mL, the obese group is 149.99 pg/mL, and the very obese group is 111.98 pg/mL.

Keywords

obesity; glucagon; diabetes mellitus; metabolic syndrome

Full Text:

PDF

References

Al-Massadi, O., Fernø, J., Diéguez, C., Nogueiras, R., & Quiñones, M. 2019. Glucagon Control on Food Intake and Energy Balance. International Journal of Molecular Science, 20, pp.1-12.

Al-Salam, S., Rashed, H., & Adeghate, E., 2011. Diabetes Mellitus is Associated with an Increased Expression of Resistin in Human Pancreatic Islet Cells. Islets, 3(5), pp.246-249.

Cavaghan, M.K., Ehrmann, D.A., & Polonsky, K.S., 2000. Interactions Between Insulin Resistance and Insulin Secretion in The Development of Glucose Intolerance. Journal of Clinical Investigation, 106(3), pp.329-333.

Chang, C.J., Jian D.Y., Lin, M.W., Zhao, J.Z., Ho, L.T., & Juan, C.C., 2015. Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity. PLoS One,10(5), pp.1-12.

Charron, M.J., & Vuguin, P.M., 2015. Lack of Glucagon Receptor Signaling and Its Implications Beyond Glucose Homeostasis. Journal of Endocrinology, 224(3), pp.R123-R30.

D’Alessio, D., 2011. The Role of Dysregulated Glucagon Secretion in Type 2 Diabetes. Diabetes, Obesity and Metabolism, 13, pp.126-132.

Grantham, J.P., & Henneberg, M., 2014. The Estrogen Hypothesis of Obesity. PLoS ONE, 9 (6), pp.1-7.

Golay, A., Swislocki, A.L.M., Chen, Y.D.I., Jaspan, J.B., & Reaven, G.M., 1986. Effect of Obesity on Ambient Plasma Glucose, Free Fatty Acid, Insulin, Growth Hormone, and Glucagon Concentrations. The Journal of Clinical Endocrinology & Metabolism, 63(2), pp.481–484.

Habegger, K.M., Heppner, K.M., Geary, N., Bartness, T.J., DiMarchi, R., & Tschöp, M.H., 2010. The Metabolic Actions of Glucagon Revisited. Nature Reviews. Endocrinology, 6(12), pp.689–697.

Hall, J.E., 2006. Guyton and Hall: Textbook of Medical Physiology. Philadelphia: Elsevier Inc.

Innocent, O., ThankGod, O.O., Sandra, E.O., & Josiah, I.E.. 2013. Correlation Between Body Mass Index and Blood Glucose Levels Among Some Nigerian Undergraduates. HOAJ Biology, 2, pp.4-6.

Kleinert, M., Sachs, S., Habegger, K.M., Hofmann, S.M., & Müller, T.D., 2019. Glucagon Regulation of Energy Expenditure. International Journal of Molecular Sciences, 20(21), pp.1-12.

Manell, H., Kristinsson, H., Kullberg, J., Ubhayasekera, S.J.K., Mörwald, K., Staaf, J., Cadamuro, J., Zsoldos, F., Gopel, S., Sargsyan, E., Ahlstrom, H., Bergquist, J., Weghuber, D., Forslund, A., & Bergsten, P., 2019. Hyperglucagonemia in Youth is Associated with High Plasma Free Fatty Acids, Visceral Adiposity and Impaired Glucose Tolerance. Pediatric Diabetes, 2019, pp.1-12.

McShane, L.M., Irwin, N., O’Flynn, D., Franklin, Z.J., Hewage, C.M., & O’Harte, F.P., 2016. Glucagon Receptor Antagonist and GIP Agonist Combination for Diet-induced Obese Mice. The Journal of Endocrinology, 229(3), pp.319–330.

Moon, J.S., & Won, K.C., 2015. Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block. Diabetes & Metabolism Journal, 39(1), pp.1-9.

Nehete, P., Magden, E.R., Nehete, B., Hanley, P.W., & Abee, C.R., 2014. Obesity Related Alterations in Plasma Cytokines and Metabolic Hormones in Chimpanzees. International Journal of Inflammation, 2014, pp.1-11

Quesada, I., Tudurí, E., Ripoll, C., & Nadal, Á., 2008. Physiology of the Pancreatic α-cell and Glucagon Secretion: Role in Glucose Homeostasis and Diabetes. Journal of Endocrinology, 199(1), pp.5-19.

Riset Kesehatan Dasar., 2013. Badan Penelitian dan Pengembangan Kesehatan. Jakarta: Kementerian Kesehatan RI.

Scott, R.V., & Bloom, S., 2018. Problem or Solution: The Strange Story of Glucagon. Peptides, 100, pp.36–41.

Shah, P., Vella, A., Basu, A., Basu, R., Schwenk, W.F., & Rizza, R.A., 2000. Lack of Suppression of Glucagon Contributes to Postprandial Hyperglycemia in Subjects with Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism, 85(11), pp.4053-4059.

Stern, J.H., Smith, G.I., Shiuwei Chen , Roger H Unger, Klein, S., & Scherer, P.E., 2020 Obesity Dysregulates Fasting-induced Changes in Glucagon Secretion. Journal of Endocrinology. 243(2), pp.149-160.

Wang, C., Li, J., Xue, H., Li, Y., Huang, J., Mai, J., Chen, J., Cao, J., Wu, X., Guo, D., Yu, L., & Gu, D. 2014. Type 2 Diabetes Mellitus Incidence in Chinese: Contributions of Overweight and Obesity. Diabetes Research and Clinical Practice, 107(3), pp.424 – 432.

Wells, J.C.K., & Victora, C.G., 2005. Indices of Whole-body and Central Adiposity for Evaluating the Metabolic Load of Obesity. International Journal of Obesity, 29(5), pp.483-489.

Ye, J., 2013. Mechanisms of Insulin Resistance in Obesity. Frontiers of medicine, 7(1), pp.14-24.

Refbacks

There are currently no refbacks.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Username
Password
Remember me